Regulus Therapeutics Inc. buy HC Wainwright
Start price
06.05.24
/
50%
€2.26
Target price
06.05.25
€8.35
Performance (%)
-1.77%
Price
20.06.24
€2.26
Summary
This prediction is currently active. With a performance of -1.77%, the BUY prediction for Regulus Therapeutics Inc. by HC_Wainwright is down slightly. This prediction currently runs until 06.05.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Regulus Therapeutics Inc. | 0.000% | 0.000% |
iShares Core DAX® | 1.080% | -2.933% |
iShares Nasdaq 100 | 0.362% | 7.015% |
iShares Nikkei 225® | -1.155% | -1.155% |
iShares S&P 500 | 0.806% | 4.388% |
Comments by HC_Wainwright for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat
Stopped prediction by HC_Wainwright for Regulus Therapeutics Inc.
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.64
25.03.24
25.03.24
€8.30
25.03.25
25.03.25
-15.91%
20.06.24
20.06.24
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.50
19.09.23
19.09.23
€8.41
19.09.24
19.09.24
50.67%
20.06.24
20.06.24